International Journal of Coronaviruses

IJCV New Year Waiver Program 2025
 

Advancing Global Understanding of Coronaviruses

The International Journal of Coronaviruses (IJCV) is dedicated to fostering high-impact research that advances our knowledge of coronaviruses, including SARS-CoV-2, and the challenges they pose. Our Waiver Program 2025, running from December 31, 2024, to February 28, 2025, is here to support researchers driving innovation in diagnostics, therapeutics, epidemiology, and public health.
 

Take advantage of up to 50% off processing charges and ensure your work reaches the global community addressing this critical area of research.
 

APC Details

• Original APC: $$2400 USD
• Waived APC: $1200 to $1800 USD
   

Let's Lead the Fight Against Coronaviruses

The fight against coronaviruses is far from over, and your research is vital. Submit your manuscript through IJCV’s Waiver Program 2025 and be part of a global effort to tackle this critical health challenge.

Submit Now

Waivers Tailored for Coronavirus Research
 

COVID-19 Innovation Waiver – 30% On APC - Payable APC is $1680 USD

• Who It’s For: Researchers presenting novel approaches to vaccines, antivirals, or diagnostic tools related to SARS-CoV-2 or other coronaviruses.
• Why It Matters: Your innovative ideas could shape the next big breakthrough in combating coronaviruses.
   

Women in Science Waiver – 40% On APC - Payable APC is $1440 USD

• Who It’s For: Women leading impactful studies on coronaviruses, long COVID, or pandemic preparedness.
• Why It Matters: Celebrate the leadership and contributions of women researchers in tackling global health challenges.

Mentorship Contribution Waiver – 25% On APC - Payable APC is $1800 USD

• Who It’s For: Collaborative studies involving mentor-mentee teams, focusing on breakthroughs in virology or therapeutics.
• Why It Matters: Acknowledge the value of mentorship in advancing impactful coronavirus research.
   

Insightful Data Analytics Waiver – 35% On APC - Payable APC is $1560 USD

• Who It’s For: Researchers leveraging big data to enhance our understanding of coronavirus epidemiology, variant tracking, or healthcare resource allocation.
• Why It Matters: Data insights are critical to pandemic preparedness and response.

Interdisciplinary Breakthrough Waiver – 30% On APC - Payable APC is $1680 USD

• Who It’s For: Researchers combining virology with fields like immunology, AI, or public health to develop comprehensive solutions.
• Why It Matters: Collaboration between disciplines is essential to address complex challenges.
   

Early Career Research Waiver – 50% On APC - Payable APC is $1200 USD

• Who It’s For: Early-career researchers within five years of earning their PhD, contributing fresh insights into coronavirus research.
• Why It Matters: Empower new voices and perspectives in the ongoing fight against coronaviruses.

Why Publish with IJCV?

• Accelerated Review and Publication: Waiver submissions receive priority processing for faster publication.
• Global Impact: Exceptional papers are spotlighted in our “Coronaviruses Research Highlights”, reaching a worldwide audience.
• Accessible Research: Waivers ensure that financial constraints do not hinder groundbreaking work from being published.

How to Apply for a Waiver

• Select Your Waiver: Choose the category that aligns with your manuscript during submission.
• Submit Your Justification: Provide a 50–100 word explanation in your cover letter or in separate letter to avail the waiver.

How to Submit

Submitting your work is simple! Choose one of the following submission methods that best fits your convenience:

• Online Submission Form: Quick and easy to use - complete your submission directly through our portal.

• Email Submission: Prefer submitting via email? Send your manuscript to info@openaccesspub.org.
• Author Registration Link: Register as an author and manage your submissions online.

Submit to Our Sister Journal

In addition to IJCV, we welcome submissions to our sister journal, the Journal of Current Viruses and Treatment Methodologies. Researchers involved in COVID-19 and coronavirus research are encouraged to explore this option for publication.

FAQS

• Can I apply for multiple waivers?
  Yes, but only the highest waiver percentage will be applied.
• When will I know if I qualify?
  You’ll receive confirmation within 7 business days.
• Do I need to pay upfront?
  No, APCs are adjusted after waiver approval.

Contact Us

For any editorial inquiries or assistance with the submission process, feel free to reach out to our team at: info@openaccesspub.org

Join us in shaping the future of global health and sharing your research with the world.

Last Updated on December 31, 2024